Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pediatr. 1995 Nov;127(5):819-22.

Bone mineral density during treatment of central precocious puberty.

Author information

  • 1Department of Pediatrics, Stanford University Medical Center, California 94305, USA.

Abstract

Treatment of adults with gonadotropin releasing hormone analogs has resulted in rapid loss in bone mineral density (BMD). We measured lumbar and femoral neck BMD by dual-energy x-ray absorptiometry during 2 years of depot leuprolide therapy in 13 girls (mean age, 7.5 years; mean bone age, 10.9 years). At baseline, BMD was elevated for age and concordant with the advanced skeletal age. During therapy with gonadotropin releasing hormone analog, BMD values increased and BMD standard deviation scores for age and skeletal age did not change.

PMID:
7472845
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk